The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXPD.L Regulatory News (XPD)

  • There is currently no data for XPD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Xpediator plc - Replacement

5 Jan 2023 13:14

RNS Number : 8442L
Cogels Investments Limited
05 January 2023
 

Replacement - Form 8 (OPD) - Xpediator plc

 

This announcement replaces the Form 8 (OPD) announcement released by Cogels Investments Limited on 4 January 2023 at 15:14 (GMT) under RNS 7035L.

 

Sections 1, 2, 3 and 4 have been updated.

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

A consortium comprising Cogels Investments Limited, funds managed by BaltCap and Justas Versnickas.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Cogels Investments Limited, the investment vehicle of Stephen Blyth.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Xpediator plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

30 December 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

5p ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

37,260,660*

 

26.30

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

37,260,660

26.30

 

 

 

All interests and all short positions should be disclosed.

\* The relevant securities referred to above are held directly by Cogels Investments Limited.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

The persons listed below are either a director of Cogels Investments Limited or a close relative of a director of Cogels Investments Limited.

 

Name

Number of ordinary shares of 5p each held

Percentage of issued share capital

Lucia Blyth

104,077

0.07%

Claudia Blyth

104,077

0.07%

Olivia Blyth

104,077

0.07%

Emilia Blyth

104,077

0.07%

George Blyth

104,077

0.07%

Frances Lee

31,223

0.02%

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 January 2023

Contact name:

Stephen Blyth

Telephone number:

+44 7801 662486

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBAMJTMTMMBLJ
Date   Source Headline
14th Sep 20207:00 amRNSHalf-year Report
9th Sep 202012:00 pmRNSNotice of Results
17th Jul 20207:00 amRNSTrading Update
2nd Jul 202012:28 pmRNSDirector/PDMR Shareholding - Scrip Dividend
19th Jun 20203:30 pmRNSScrip Dividend Reference Price
5th Jun 20207:00 amRNSDirectorate Change
26th May 20203:45 pmRNSResult of AGM
26th May 20207:00 amRNSAGM Statement
21st May 20202:00 pmRNSScrip Dividend
4th May 20202:45 pmRNSNotice of AGM
20th Apr 20207:00 amRNSFinal Results
31st Mar 20207:00 amRNSCOVID-19 Update
4th Mar 20207:00 amRNSNew Warehouse Extension in Southampton Port
18th Feb 20207:00 amRNSDirectorate Update
10th Feb 20207:00 amRNSTrading Statement
5th Dec 201910:30 amRNSDirector/PDMR Shareholding
2nd Dec 20197:00 amRNSIssue of Equity
29th Nov 201911:30 amRNSDirector/PDMR Shareholding
27th Nov 201910:50 amRNSDirector/PDMR Shareholding
25th Nov 20192:30 pmRNSDirector/PDMR Shareholding
21st Nov 20193:45 pmRNSDirector/PDMR Shareholding
14th Nov 201910:15 amRNSDirector/PDMR Shareholding
13th Nov 20197:00 amRNSDirectorate Change
4th Nov 20197:00 amRNSDirectorate Change
26th Sep 20197:00 amRNSHalf-year Report
6th Sep 20197:00 amRNSDirectorate Change
7th Aug 20197:00 amRNSChange of Adviser
30th Jul 20192:05 pmRNSSecond Price Monitoring Extn
30th Jul 20192:00 pmRNSPrice Monitoring Extension
30th Jul 20197:00 amRNSTrading Statement
25th Jun 20197:00 amRNSIssue of Equity
6th Jun 20194:50 pmRNSResult of AGM
6th Jun 20197:00 amRNSBoard Changes and Trading Update
4th Jun 201911:00 amRNSDirector/PDMR Shareholding
31st May 20197:00 amRNSTotal Voting Rights
16th May 201910:00 amRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSIssue of Equity
10th May 20197:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20197:00 amRNSDirector/PDMR Shareholding
29th Apr 20197:00 amRNSFinal Results
26th Apr 20199:30 amRNSUpdate on Intereuropa and Notice of Results
4th Mar 20197:00 amRNSSenior Management Appointment
18th Feb 20197:00 amRNSTrading Statement
17th Jan 20197:00 amRNSSenior Management Appointment
16th Jan 20194:43 pmRNSStatement re Press Comment
27th Dec 201811:52 amRNSIssue of Equity
4th Dec 201811:05 amRNSSecond Price Monitoring Extn
4th Dec 201811:00 amRNSPrice Monitoring Extension
27th Nov 20187:00 amRNSDirector/PDMR Shareholding
23rd Nov 201811:30 amRNSXpediator to present at Mello London

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.